Heavy Bleeding in Perimenopause: What's Normal, What's Not, and What Stops It

Heavier bleeding in perimenopause is a progesterone problem, not an estrogen deficiency problem — which surprises most people, because perimenopause is usually described as a time of falling hormones.

Here is the actual sequence. In a regular ovulatory cycle, an egg is released and the follicle it came from becomes a structure called the corpus luteum, which produces progesterone for the second half of the cycle. Progesterone's job in the uterus is to stabilize and mature the lining, then withdraw cleanly so the lining sheds in an organized, predictable way.

In perimenopause, ovulation becomes erratic. Some cycles you ovulate; many you do not. A cycle without ovulation is called anovulatory, and it produces no corpus luteum and therefore no meaningful progesterone. Meanwhile estrogen keeps being produced — often in higher and more volatile amounts than in your thirties, because the brain raises FSH to push increasingly resistant ovaries, and the ovaries sometimes respond with an estrogen surge.

The result is unopposed estrogen: a lining that keeps thickening with nothing to organize or limit it. When it finally becomes too thick to sustain its own blood supply, it breaks down chaotically rather than shedding cleanly. That is what produces the flooding, the clots, the 10-day periods, and the unpredictable timing.

This also explains the pattern most women describe — heavy periods interspersed with skipped ones. A skipped month is often a longer build; the period that follows it is correspondingly heavier. Our overview of [perimenopause weight gain](/blog/perimenopause-weight-gain-why-it-happens-swan-data) covers the same hormonal volatility from a metabolic angle, and [what an FSH test really tells you](/blog/fsh-test-for-perimenopause-what-it-actually-tells-you) explains why bloodwork so often fails to confirm what your cycle is already telling you.

Far more common than most women are told. The Study of Women's Health Across the Nation (SWAN) followed a large multi-ethnic cohort of midlife women with detailed bleeding diaries, and the findings published by Paramsothy and colleagues in *BJOG* (2014) reframed what counts as typical.

Across roughly a decade of follow-up, about 91% of participants recorded at least one episode of bleeding lasting 10 or more days. The majority also recorded multiple occurrences of heavy flow and extended spotting. In other words, prolonged and heavy bleeding was not the exception during the transition — it was close to universal at some point.

That statistic is genuinely reassuring in one direction and misleading in another.

It is reassuring because it means a 10-day period, or a month where you bleed through your usual protection, does not by itself imply pathology. Many women spend years quietly worried that something is seriously wrong when what is happening is a well-documented feature of the transition.

It is misleading because 'common' has been used for decades to dismiss women whose bleeding genuinely warranted investigation. Fibroids, endometrial polyps, adenomyosis, and endometrial hyperplasia all peak in exactly this age range, and all present with heavy or irregular bleeding. The SWAN data tells you the base rate is high. It does not tell you that *your* bleeding is benign.

The useful posture is neither panic nor dismissal: treat heavy perimenopausal bleeding as common but worth characterizing. Track it, quantify it, and know which specific features move it from expected to urgent.

The clinical definition of heavy menstrual bleeding has moved away from measuring millilitres, because nobody does that in real life. The working definition now is blood loss that interferes with your physical, social, emotional, or material quality of life. If you are planning your week around your period, that qualifies.

The practical markers clinicians use:

• •Soaking through a pad or tampon every hour for two or more consecutive hours
• •Needing double protection — a tampon and a pad together — to get through the day
• •Passing clots larger than a quarter (about 2.5 cm)
• •Bleeding for more than 7 days
• •Waking overnight to change protection
• •Bleeding through clothing or bedding
• •Symptoms of anemia: breathlessness on stairs, unusual fatigue, palpitations, ice cravings

Separately, there are patterns that always warrant evaluation regardless of volume, because they carry different diagnostic weight:

Bleeding between periods. Intermenstrual bleeding can reflect a polyp, a fibroid distorting the cavity, or endometrial change.

Bleeding after sex. Post-coital bleeding needs a cervical assessment.

Bleeding after 12 or more months without a period. This is postmenopausal bleeding and it is a different category entirely. It should never be attributed to perimenopause, because by definition perimenopause has ended. A meta-analysis by Clarke and colleagues (*JAMA Internal Medicine*, 2018) found that roughly 9% of women presenting with postmenopausal bleeding had endometrial cancer, and that around 90% of women diagnosed with endometrial cancer had reported bleeding. That is a high enough yield that every episode gets investigated — and it is also why postmenopausal bleeding is one of the few gynecological symptoms with an excellent prognosis when acted on early.

A reasonable workup for heavy perimenopausal bleeding is fairly standardized, and knowing it in advance helps you ask for what you need rather than accepting 'it's just your age.'

Bloodwork. A full blood count is the minimum, but hemoglobin alone is not enough. Ferritin — your iron stores — falls long before hemoglobin does, so you can be significantly iron-deficient with a 'normal' blood count. Many clinicians consider ferritin below 30 ng/mL as deficient in menstruating women, and symptoms often appear well before that. Thyroid function is also standard, because thyroid dysfunction causes both heavy bleeding and symptoms that overlap heavily with perimenopause; our guide to [telling thyroid from perimenopause](/blog/thyroid-or-perimenopause-overlapping-symptoms-what-to-test) covers that overlap.

Transvaginal ultrasound. This visualizes the uterus and measures endometrial thickness, and it identifies fibroids, polyps, and features suggestive of adenomyosis. It is the standard first-line imaging.

Endometrial biopsy. An office procedure taking a small sample of the uterine lining, used to exclude hyperplasia and cancer. It is typically recommended for women over 45 with abnormal bleeding, for anyone with persistent bleeding despite treatment, and for anyone with postmenopausal bleeding. It is brief and uncomfortable rather than painful for most women — ask about pain management options in advance, because provision varies widely.

Hysteroscopy or saline infusion sonography. Used when ultrasound suggests a polyp or submucosal fibroid, allowing direct visualization and often removal in the same procedure.

What you can bring that makes all of this faster: a bleeding log. Dates, duration, number of products used per day, clot size, and any bleeding outside a period. Three months of that data is more diagnostically useful than any description from memory, and it makes it considerably harder for your bleeding to be waved through as unremarkable.

There are effective treatments, and most women are offered far fewer of them than exist. The options range from non-hormonal to surgical, and the right one depends on your cause, your contraceptive needs, and how close you are to your final period.

Levonorgestrel intrauterine system (the hormonal IUD). For most women this is the most effective non-surgical option, reducing menstrual blood loss dramatically — commonly by 70-95% — and often stopping periods entirely within a year. It delivers progestogen directly to the endometrium, which addresses the unopposed-estrogen problem at its source. It also provides contraception, which still matters in perimenopause, and it can serve as the progestogen component if you later add estrogen for symptom control. Our guide to [birth control in perimenopause](/blog/birth-control-in-perimenopause-what-to-use-after-40) covers how those roles overlap.

Tranexamic acid. A non-hormonal tablet taken only on heavy days that stabilizes clot breakdown, typically reducing blood loss by around 40%. It does not affect your cycle or your hormones, which makes it useful for women who want a targeted fix without ongoing treatment.

NSAIDs. Mefenamic acid or naproxen started at the onset of bleeding reduce loss modestly and help with cramping. Less effective than the options above, but easy and additive.

Cyclical or continuous progestogen. Oral progesterone or norethisterone can regulate the lining and impose a predictable bleed. Useful particularly where an IUD is not wanted.

Combined hormonal contraception. For women without contraindications, this regulates cycles, lightens bleeding, and controls perimenopausal symptoms simultaneously.

Endometrial ablation. A day procedure that destroys the uterine lining. Effective for bleeding, but it is only for women who have completed childbearing and it makes future endometrial monitoring harder.

Myomectomy or hysterectomy. Reserved for significant structural disease or failure of other treatments.

Alongside any of these, treat the iron. Heavy bleeding is the leading driver of iron deficiency in midlife women, and iron deficiency is responsible for a great deal of the fatigue, breathlessness, and brain fog that gets attributed to hormones alone.

The honest answer is that it varies enormously, and that uncertainty is part of what makes it hard to live with.

Using the STRAW+10 staging system (Harlow et al., 2012) — the standard framework for describing the transition — heavy and irregular bleeding is most characteristic of late perimenopause, the stage defined by gaps of 60 days or more between periods. That stage typically lasts one to three years before the final menstrual period, though the full transition from the first cycle irregularity can span four to eight years or more.

What that means practically: if your bleeding has recently become erratic and heavy, you may be looking at a period of months to a few years rather than a permanent state. Bleeding generally becomes lighter and less frequent as estrogen production declines toward the end of the transition, and it stops entirely at menopause.

But 'it will pass' is not a treatment plan. Two to three years of flooding, anemia, and rearranged plans is a substantial portion of your life, and the treatments above work now rather than eventually. The women who fare best are not the ones who wait it out — they are the ones who characterize the bleeding, rule out structural causes, correct their iron, and treat the bleeding itself while the transition takes however long it takes.

One last flag worth holding onto: once you have gone 12 consecutive months without a period, you are postmenopausal, and any bleeding after that point is not perimenopause. It is a new symptom in a new stage, and it gets evaluated on its own terms — promptly, and every single time.